Open account
Sign up/Log in
Cellectar Biosciences Inc reports results for the quarter ended in December - Earnings Summary
Cellectar Biosciences Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of 61 cents per share. The mean expectation of four analysts was for a loss of 57 cents. The average analyst rating on the shares is "strong buy"
Reuters · 03/27 13:31
BUZZ-U.S. STOCKS ON THE MOVE-Akero Therapeutics, Vista Outdoor, Sea
Dow Jones Industrial Average down 0.20% on Monday. S&P 500 and Nasdaq's record-closing highs in the prior session. Akero Therapeutics, Vista Outdoor, Sea are among the day's top stocks on thedaq. The U.S. Markets are set to open on a down day.
Reuters · 03/04 19:01
BUZZ-U.S. STOCKS ON THE MOVE-Super Micro, Decker, Rumble
Wall Street's main indexes dipped on Monday after the S&P 500 and the Nasdaq's record-closing highs in the prior session. The Dow Jones Industrial Average was down 0.24% at 38,994.68. The Nasdaq Composite was also down on the day. Super Micro, Decker, Rumble among the stocks on the move.
Reuters · 03/04 16:08
BUZZ-Cellectar Biosciences up on positive data from early-stage cancer therapy trial
Cellectar Biosciences up on positive data from early-stage cancer therapy trial. Shares of drug developer rise 7.6% to $4.52 premarket. Co says its experimental cancer therapy in combination with radiation therapy was safe and tolerated in the study.
Reuters · 03/04 14:02
BUZZ-U.S. STOCKS ON THE MOVE-Halozyme, Scorpio Tankers
Wall Street's main indexes fell on Tuesday after mixed earnings from Morgan Stanley and Goldman Sachs. Dow Jones Industrial Average was down 0.61% and the S&P 500 and Nasdaq Composite were also down. Boeing and Apple were among the biggest decliners, with declines in both companies.
Reuters · 01/16 18:54
BUZZ-Cellectar rises on positive data for pancreatic cancer treatment
Cellectar Biosciences rises on positive data for pancreatic cancer treatment. Shares of Cellectar rise 4.6% to $3.67. Drug developer expects to start early-stage human trials for the drug later this year or early next year. Stock rose 62% in 2023.
Reuters · 01/16 17:50
BUZZ-U.S. STOCKS ON THE MOVE-Core & Main, Commercial Metals, Equifax
Tech-laden Nasdaq jumped more than 1% to a one-week high on Monday. Dow slipped to a fresh two-week low as Boeing shares tanked following the grounding of some jets. Top three S&P 500 percentage gainers: Baxter International, American Airlines Group.
Reuters · 01/08 19:09
BUZZ-U.S. STOCKS ON THE MOVE-Toll Brothers, American Eagle Outfitters, Twilio
U.S. Blue-chip index Dow slipped to a fresh two-week low on Monday. Boeing shares fell following the grounding of some its jets. The rebound in megacaps and chip stocks supported the other U.s. Stock indexes. The Dow Jones Industrial Average was down 0.13% at 37,416.29.
Reuters · 01/08 15:57
Webull offers CELLECTAR BIOSC stock information, including NASDAQ: CLRBZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLRBZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading CLRBZ stock methods without spending real money on the virtual paper trading platform.